top of page
Biology Class

Our Focus

We are developing a novel allergen immunotherapy that aims to provide not just a safe and effective therapy for food allergy patients, but also one that is convenient and fits into a family's lifestyle. Our first treatment is focused on reducing the risk of an anaphylactic reaction in patients with peanut allergy from an accidental exposure to peanuts. 
Sahil peanut butter screenshot.png

Peanut allergy 

Peanut allergies are more common now than ever.

  • There are over 6 million people in the USA alone with a peanut allergy. Over 1.5 million are children and teenagers. 

  • About eight out of every ten children never outgrow a peanut allergy. 

  • Nearly 1 in every 5 peanut allergic  children in the USA visit the emergency room following allergic reaction from peanuts.  


Microneedle Patch Moonlight Therapeutics (2).jpg


The MOON101 therapy is designed with a focus on not just safety and efficacy but also convenience to the patient and family.

  • No risk of oral ingestion or taste aversion expected

  • No expectation of gastrointestinal side effects 

  • Less than 5 minute application

  • No prolonged updosing period or bi-weekly clinic visits expected

  • At-home therapy

  • No restriction of activities expected after therapyNo 

bottom of page